FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.435
+0.016 (3.77%)
At close: Mar 6, 2026, 4:00 PM EST
0.430
-0.005 (-1.13%)
After-hours: Mar 6, 2026, 7:56 PM EST
FibroBiologics Employees
FibroBiologics had 15 employees as of December 31, 2025. The number of employees increased by 2 or 15.38% compared to the previous year.
Employees
15
Change (1Y)
2
Growth (1Y)
15.38%
Revenue / Employee
n/a
Profits / Employee
-$1,243,067
Market Cap
29.40M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15 | 2 | 15.38% |
| Dec 31, 2024 | 13 | 3 | 30.00% |
| Dec 31, 2023 | 10 | 3 | 42.86% |
| Dec 31, 2022 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Kyntra Bio | 225 |
| IGC Pharma | 70 |
| Evaxion | 46 |
| Cue Biopharma | 41 |
| Werewolf Therapeutics | 39 |
| Lantern Pharma | 24 |
| NeuroSense Therapeutics | 17 |
| Edesa Biotech | 17 |
FBLG News
- 2 days ago - FibroBiologics Completes Site Onboarding for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers - GlobeNewsWire
- 5 days ago - FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis - GlobeNewsWire
- 9 days ago - FibroBiologics to Present at the BIO Investment & Growth Summit - GlobeNewsWire
- 11 days ago - FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 12 days ago - FibroBiologics Granted Extension by Nasdaq to Regain Compliance - GlobeNewsWire
- 25 days ago - FibroBiologics' Chairman & CEO Pete O'Heeron Selected to Present at A4LI's H-SPAN Summit at Georgetown University - GlobeNewsWire
- 4 weeks ago - FibroBiologics Announces Issuance of Canadian Patent Covering Novel Fibroblast-Based Treatment for Cachexia - GlobeNewsWire
- 6 weeks ago - FibroBiologics to Present at the DealFlow Discovery Conference - GlobeNewsWire